Cetera Investment Advisers
ARKG icon

Cetera Investment Advisers’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cetera Investment Advisers’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.17M Buy
122,914
+21,042
+21% +$670K ﹤0.01% 1597
2026
Q1 		$2.69M Sell
101,872
-2,023
-2% -$59.2K ﹤0.01% 2001
2025
Q4 		$3.01M Sell
103,895
-12,180
-10% -$366K ﹤0.01% 1854
2025
Q3 		$3.22M Buy
116,075
+24,412
+27% +$617K ﹤0.01% 1767
2025
Q2 		$2.23M Sell
91,663
-9,329
-9% -$204K ﹤0.01% 1760
2025
Q1 		$2.1M Sell
100,992
-3,187
-3% -$80.1K ﹤0.01% 1718
2024
Q4 		$2.45M Sell
104,179
-6,010
-5% -$148K 0.01% 1505
2024
Q3 		$2.82M Sell
110,189
-8,608
-7% -$219K 0.01% 1368
2024
Q2 		$2.79M Sell
118,797
-22,100
-16% -$558K 0.01% 1329
2024
Q1 		$4.05M Buy
140,897
+104,831
+291% +$3.15M 0.01% 1094
2023
Q4 		$1.18M Sell
36,066
-3,392
-9% -$92.2K 0.01% 1011
2023
Q3 		$1.1M Sell
39,458
-1,755
-4% -$57.4K 0.01% 1006
2023
Q2 		$1.4M Buy
41,213
+828
+2% +$26K 0.01% 929
2023
Q1 		$1.21M Buy
40,385
+1,474
+4% +$45.7K 0.01% 943
2022
Q4 		$1.1M Buy
38,911
+1,522
+4% +$48.3K 0.01% 956
2022
Q3 		$1.23M Sell
37,389
-6,354
-15% -$233K 0.02% 635
2022
Q2 		$1.38M Sell
43,743
-1,371
-3% -$47.9K 0.02% 663
2022
Q1 		$2.07M Sell
45,114
-4,149
-8% -$198K 0.03% 550
2021
Q4 		$3.02M Sell
49,263
-13,492
-21% -$933K 0.04% 420
2021
Q3 		$4.69M Sell
62,755
-1,914
-3% -$161K 0.07% 277
2021
Q2 		$5.98M Sell
64,669
-30,466
-32% -$2.59M 0.1% 230
2021
Q1 		$8.44M Buy
95,135
+17,067
+22% +$1.69M 0.17% 131
2020
Q4 		$7.28M Buy
78,068
+64,665
+482% +$5.15M 0.14% 157
2020
Q3 		$854K Buy
+13,403
New +$785K 0.07% 281

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cetera Investment Advisers's ARKG Position: Q2 2026 in Review

Cetera Investment Advisers increased its ARK Genomic Revolution ETF (ARKG) stake by 21% in Q2 2026, buying an estimated $670K and bringing the position to 122,914 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Cetera Investment Advisers first reported a position in ARKG in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.44M in Q1 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Cetera Investment Advisers held 122,914 shares of ARK Genomic Revolution ETF worth $5.17M as of Q2 2026.
  • Cetera Investment Advisers bought 21,042 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $670K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1597 holding.
  • Cetera Investment Advisers first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 24 quarters since.
  • Cetera Investment Advisers's ARK Genomic Revolution ETF position peaked at $8.44M in Q1 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.